Home › Funds › Tao Capital Management LP › MDGL

Tao Capital Management LP position in MDGL

MADRIGAL PHARMACEUTICALS INC · Health Care

Tao Capital Management LP reported holding 21,000 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$10.6M, representing 1.02% of its reported portfolio and ranking #5 among its reported holdings. Tao Capital Management LP has disclosed MDGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)21.00K sh
Reported value held$10.58M
Portfolio Weight1.02%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Tao Capital Management LP's MDGL position evolved

Tao Capital Management LP first disclosed a stake in MDGL in Q3 2023 at 77,657 shares (US$11.3M). The position peaked in Q4 2024 at 130,529 shares, worth US$40.3M. Across 13 filings, Tao Capital Management LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 21,000 shares valued at US$10.6M. Notable position changes include a 68% increase in Q4 2023 (shares rose 15% over the following quarter), a 64% trim in Q3 2025 (shares rose 27% over the following quarter), a 49% trim in Q4 2025 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 77.66K $11.34M New
Q4 2023 130.53K $30.20M Add
Q1 2024 130.53K $34.86M Hold
Q2 2024 130.53K $36.57M Hold
Q3 2024 130.53K $27.70M Hold
Q4 2024 130.53K $40.28M Hold
Q1 2025 112.78K $37.36M Reduce
Q2 2025 112.78K $34.13M Hold
Q3 2025 41.00K $18.81M Reduce
Q4 2025 21.00K $12.23M Reduce
Q1 2026 21.00K $10.99M Hold
Q2 2026 21.00K $11.28M Hold
Q3 2026 21.00K $10.58M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDGL and 13F data

MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 46 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), RTW INVESTMENTS, LP (US$1.07B), Janus Henderson Group (US$1.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDGL

All MDGL fund holders →

FAQ

How long has Tao Capital Management LP held MDGL?

Tao Capital Management LP has disclosed MDGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Tao Capital Management LP's current position in MDGL?

As of Q3 2026, Tao Capital Management LP holds 21.00K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $10.58M, representing 1.02% of its reported portfolio and ranking #5.

Has Tao Capital Management LP been buying or selling MDGL?

In the latest 13F filing (Q3 2026), Tao Capital Management LP held unchanged its position in MDGL. The position peaked in Q4 2024 at 130.53K shares.

Which other funds hold MDGL?

Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Janus Henderson Group, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.